Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Revenue

Lexaria Bioscience had revenue of $386.00K in the twelve months ending February 29, 2024, with 17.46% growth year-over-year. Revenue in the quarter ending February 29, 2024 was $145.00K with 624.09% year-over-year growth. In the fiscal year ending August 31, 2023, Lexaria Bioscience had annual revenue of $226.21K, a decrease of -11.43%.

• Revenue (ttm): $386.00K
• Revenue Growth: +17.46%
• P/S Ratio: 111.91
• Revenue / Employee: $77,199
• Employees: 5
• Market Cap: 43.20M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2023	226.21K	-29.19K	-11.43%
Aug 31, 2022	255.40K	-467.34K	-64.66%
Aug 31, 2021	722.74K	407.95K	129.59%
Aug 31, 2020	314.79K	92.18K	41.41%
Aug 31, 2019	222.61K	-210.68K	-48.62%
Aug 31, 2018	433.29K	369.65K	580.85%
Aug 31, 2017	63.64K	22.92K	56.29%
Aug 31, 2016	40.72K	26.02K	176.96%
Aug 31, 2015	14.70K	-	-
Aug 31, 2014	0	-	-
Oct 31, 2013	0	-	-
Oct 31, 2012	1.36M	224.00K	19.76%
Oct 31, 2011	1.13M	771.30K	212.79%
Oct 31, 2010	362.47K	-59.48K	-14.10%
Oct 31, 2009	421.96K	-478.83K	-53.16%
Oct 31, 2008	900.79K	647.64K	255.83%
Oct 31, 2007	253.15K	232.84K	1,146.60%
Oct 31, 2006	20.31K	-	-
Oct 31, 2005	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.